Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioblastoma 3Oligodendroglioma 2Neoplasm Metastasis 2Glioma 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Pharyngeal Neoplasms 1Penile Neoplasms 1Parotid Neoplasms 1

Interventions

Patient Reported Outcome Measures 2Neuropsychological Tests 2lithium sulfate 1XENP 1595 1Tablets 1Sodium Chloride 1Ramipril 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Quality of Life 1Pioglitazone 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Lithium 1G(M1) Ganglioside 1Donepezil 1Climate Anxiety 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Quality of Life × CNS × Clear all
NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Completed
267 enrolled
CNS

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡